Institutional investors purchased a net $2.2 million shares of GENE during the quarter ended June 2016, and now own 16.91% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 1.1 Million shares of Genetic Technologies Ltd
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 923.4 Thousand shares of Genetic Technologies Ltd